Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients

Journal of Proteome Research

Volumn 8, Issue 3, 2009, Pages 1255-1262

  Liu, Xiaojun ^a   Feng, Qiping ^b   Chen, Yong ^c   Zuo, Jin ^a   Gupta, Nishith ^d   Chang, Yongsheng ^a,e   Fang, Fude ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b MAYO GRADUATE SCHOOL   (United States)

^c LANZHOU UNIVERSITY   (China)

^d HUMBOLDT UNIVERSITY   (Germany)

^e INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Galectin 1; Matrix assisted laser desorption ionization time of flight mass spectrometry; Two dimensional gel electrophoresis; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN A1; GALECTIN 1; PLASMA PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; AMINO ACID SEQUENCE; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GALECTIN 1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS;

EID: 65249190795     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800850a     Document Type: Article

References (33)

1. Gerich, J. E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 1998, 19 (4), 491-503.
2. Gloyn, A. L. The search for type 2 diabetes genes. Ageing Res. Rev. 2003, 2 (2), 111-27.
3. Lapolla, A.; Brioschi, M.; Banfi, C.; Tremoli, E.; Bonfante, L.; Cristoni, S.; Seraglia, R.; Traldi, P. On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients. J. Mass Spectrom. 2008, 43 (1), 74-81.
4. Brichory, F.; Beer, D.; Le Naour, F.; Giordano, T.; Hanash, S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res. 2001, 61 (21), 7908-12.
5. Sadowski, H. B.; Wheeler, T. T.; Young, D. A. Gene expression during 3T3-L1 adipocyte differentiation. Characterization of initial responses to the inducing agents and changes during commitment to differentiation. J. Biol. Chem. 1992, 267 (7), 4722-31.
6. Levenson, R. M.; Blackshear, P. J. Insulin-stimulated protein tyrosine phosphorylation in intact cells evaluated by giant two-dimensional gel electrophoresis. J. Biol. Chem. 1989, 264 (33), 19984-93.
7. Lynch, C. J.; Brennan, W. A., Jr.; Vary, T. C.; Carter, N.; Dodgson, S. J. Carbonic anhydrase III in obese Zucker rats. Am. J. Physiol. 1993, 264 (4 Pt 1), E621-30.
8. Sundsten, T.; Eberhardson, M.; Goransson, M.; Bergsten, P. The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes. Proteome Sci. 2006, 4, 22.
9. Wang, J.; Xue, Y.; Feng, X.; Li, X.; Wang, H.; Li, W.; Zhao, C.; Cheng, X.; Ma, Y.; Zhou, P.; Yin, J.; Bhatnagar, A.; Wang, R.; Liu, S. An analysis of the proteomic profile for Thermoanaerobacter teng-congensis under optimal culture conditions. Proteomics 2004, 4 (1), 136-50.
10. Li, X.; Wang, X.; Zhao, K.; Zhou, Z.; Zhao, C.; Yan, R.; Lin, L.; Lei, T.; Yin, J.; Wang, R.; Sun, Z.; Xu, Z.; Bao, J.; Zhang, X.; Feng, X.; Liu, S. A novel approach for identifying the heme-binding proteins from mouse tissues. Genomics, Proteomics Bioinf. 2003, 1 (1), 78-86.
11. Liu, X. J.; Yang, C.; Gupta, N.; Zuo, J.; Chang, Y. S.; Fang, F. D. Protein kinase C-zeta regulation of GLUT4 translocation through Actin remodeling in CHO cells. J. Mol. Med. 2007, 85 (8), 851-61.
12. Hu, S.; Loo, J. A.; Wong, D. T. Human body fluid proteome analysis. Proteomics 2006, 6 (23), 6326-53.
13. Hunt, S. M.; Thomas, M. R.; Sebastian, L. T.; Pedersen, S. K.; Harcourt, R. L.; Sloane, A. J.; Wilkins, M. R. Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J. Proteome Res. 2005, 4 (3), 809-19.
14. Escoubas, P.; Chamot-Rooke, J.; Stocklin, R.; Whiteley, B. J.; Corzo, G.; Genet, R.; Nakajima, T. A comparison of matrix-assisted laser desorption/ionization time-of-flight and liquid chromatography electrospray ionization mass spectrometry methods for the analysis of crude tarantula venoms in the Pterinochilus group. Rapid Commun. Mass Spectrom. 1999, 13 (18), 1861-8.
15. Rader, D. J. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 2003, 92 (4A), 42J-49J.
16. Rohrer, L.; Hersberger, M.; von Eckardstein, A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr. Opin. Lipidol. 2004, 15 (3), 269-78.
17. Walldius, G.; Jungner, I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J. Intern. Med. 2006, 259 (5), 493-519.
18. Ginsberg, H. N.; Zhang, Y. L.; Hernandez-Ono, A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 2005, 36 (3), 232-40.
19. Yamato, K.; Tamasawa, N.; Murakami, H.; Matsui, J.; Tanabe, J.; Suda, T.; Yasujima, M. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I. Diabetes Res. Clin. Pract. 2005, 69 (2), 124-8.
20. Tamsma, J. T.; Beverdam, F. H.; Leuven, J. A.; Lemkes, H. H. Decreased interstitial apolipoprotein A-I levels in IDDM patients with diabetic nephropathy. Diabetes 1995, 44 (5), 501-5.
21. Folin, M.; Chinello, G. E.; Contiero, E.; Vaselli, G. M. Preliminary research on apolipoprotein A-I and A-II in patients with non-insulin-dependent diabetes mellitus (NIDDM). Haematologica 1993, 78 (5), 277-81.
22. Horng, Y. C.; Wei, J. S.; Chang, R. S.; Huang, H. S.; Huang, M. J.; Huang, B. Y. Apolipoprotein levels in normolipidemic non-insulin-dependent diabetes mellitus. J. Formosan Med. Assoc. 1992, 91 (6), 590-4.
23. Camby, I.; Le Mercier, M.; Lefranc, F.; Kiss, R. Galectin-1: a small protein with major functions. Glycobiology 2006, 16 (11), 137R-157R.
24. Hui, H.; Dotta, F.; Di Mario, U.; Perfetti, R. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J. Cell Physiol. 2004, 200 (2), 177-200.
25. Donath, M. Y.; Halban, P. A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabeto-logia 2004, 47 (3), 581-9.
26. Perillo, N. L.; Marcus, M. E.; Baum, L. G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol. Med. 1998, 76 (6), 402-12.
27. Scott, K.; Weinberg, C. Galectin-1: a bifunctional regulator of cellular proliferation. Glycoconj. J. 2004, 19 (7-9), 467-77.
28. Yang, R. Y.; Liu, F. T. Galectins in cell growth and apoptosis. Cell. Mol. Life Sci. 2003, 60 (2), 267-76.
29. Sotomayor, C. E.; Rabinovich, G. A. Galectin-1 induces central and peripheral cell death: implications in T-cell physiopathology. Dev. Immunol. 2000, 7 (2-4), 117-29.
30. Pricci, F.; Leto, G.; Amadio, L.; Iacobini, C.; Romeo, G.; Cordone, S.; Gradini, R.; Barsotti, P.; Liu, F. T.; Di Mario, U.; Pugliese, G. Role of galectin-3 as a receptor for advanced glycosylation end products. Kidney Int. Suppl. 2000, 77, S31-9.
31. Pugliese, G.; Pricci, F.; Leto, G.; Amadio, L.; Iacobini, C.; Romeo, G.; Lenti, L.; Sale, P.; Gradini, R.; Liu, F. T.; Di Mario, U. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes 2000, 49 (7), 1249-57.
32. Pugliese, G.; Pricci, F.; Iacobini, C.; Leto, G.; Amadio, L.; Barsotti, P.; Frigeri, L.; Hsu, D. K.; Vlassara, H.; Liu, F. T.; Di Mario, U. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. Faseb J. 2001, 15 (13), 2471-9.
33. Stitt, A. W.; McGoldrick, C.; Rice-McCaldin, A.; McCance, D. R.; Glenn, J. V.; Hsu, D. K.; Liu, F. T.; Thorpe, S. R.; Gardiner, T. A. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 2005, 54 (3), 785-94.